PDE5 to keep them alive: The use of phosphodiesterase type-5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease.

Overview publication

TitlePDE5 to keep them alive: The use of phosphodiesterase type-5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease.
Date2023-03-01
Issue nameRespirology (Carlton, Vic.)
Issue numberv28.3:212-214
DOI10.1111/resp.14399
PubMed36318987
AuthorsWeatherald J & Humbert M
Keywordsinterstitial lung disease, phosphodiesterase type 5 inhibitor, pulmonary fibrosis, pulmonary hypertension, sildenafil, tadalafil, treatment
Read Read publication